We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Proteinuria Helps Predict Complications Following Bypass Surgery

By HospiMedica International staff writers
Posted on 29 Dec 2010
Patients with mild or heavy proteinuria are more likely to experience cardiac surgery associated acute kidney injury (CSA-AKI) after coronary artery bypass grafting (CABG), according to a new study.

Researchers at the National Taiwan University Hospital (Yun-Lin Branch, Douliou City, Taiwan) studied 1,052 adult patients undergoing CABG at the Yun-Lin Branch and its two affiliate hospitals between 2003 and 2007. More...
Kidney injury associated with the surgery arose in 183 (17.4%) of the patients, with 50 patients (4.8%) requiring renal replacement therapy. Patients with mild proteinuria (trace to 1+) were 1.66 times more likely to experience CSA-AKI when compared with patients who did not have proteinuria. Those patients with more severe proteinuria (2+ to 4+) were 2.30 times more likely to experience CSA-AKI, and 7.29 times more likely to need dialysis or a kidney transplant. The study was published early online on November 29, 2010, in the Journal of the American Society of Nephrology.

"We have found that proteinuria is potentially a risk factor of postoperative acute kidney injury; however, this simple test is usually neglected in current practice,” said study coauthor Kwan-Dun Wu, MD, PhD. "These findings should motivate clinicians to become more concerned about the presence of low quantities of protein in the urine.”

CSA-AKI is one of the most significant and severe complications after cardiac surgery, with estimates of its incidence ranging from 1-30%. In its most severe form, CSA-AKI necessitates renal replacement therapy and has a mortality rate of 50% - 60%. The pathogenesis of CSA-AKI involves multiple pathways, including hemodynamic, inflammatory, and nephrotoxic factors, which also overlap each other in leading to the kidney injury.

Related Links:

National Taiwan University Hospital





Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.